Johnson & Johnson Slashes Outlook, Races To Develop Coronavirus Vaccine
Video Credit: CBS 3 Philly - Duration: 00:37s - Published
Johnson & Johnson Slashes Outlook, Races To Develop Coronavirus Vaccine
The world’s biggest health products maker on Tuesday said it now expects 2020 revenue of $77.5 billion to $80.5 billion.
Katie Johnston reports.
